Polymorphisms of the ADAM33 gene and chronic obstructive pulmonary disease risk: A meta-analysis

Clinical Respiratory Journal

Volumn 8, Issue 1, 2014, Pages 108-115

  Aierken, Haidiya ^a   Wang, Jing ^a   Wushouer, Qimanguli ^a   Shayhidin, Elnur ^b   Hu, Xing ^a   Syed, Ikramullah ^a   Wufuer, Dilinuer ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ADAM33; COPD; Meta analysis; Polymorphisms

Indexed keywords

ADAM33 GENE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA POLYMORPHISM; EMBASE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENETIC MODEL; GENETIC RISK; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL;

ADAM33; COPD; META-ANALYSIS; POLYMORPHISMS;

ADAM PROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT;

EID: 84891829480     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12046     Document Type: Article

References (20)

1. Hogg JC, Chu F, Utokaparch S, etal. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26): 2645-2653.
2. Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol. 1998;10(5): 654-659.
3. Primakoff P, Myles DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 2000;16(2): 83-87.
4. Umland SP, Garlisi CG, Shah H, etal. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am J Respir Cell Mol Biol. 2003;29(5): 571.
5. Zou J, Zhu F, Liu J, etal. Catalytic activity of human ADAM33. J Biol Chem. 2004;279(11): 9818-9830.
6. Barnes PJ. Mechanisms in COPD differences from asthma. Chest J. 2000;117(Suppl. 2): 10S-14.
7. Puxeddu I, Pang YY, Harvey A, etal. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J Allergy Clin Immunol. 2008;121(6): 1400-1406. e4.
8. Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest J. 2005;127(3): 965-972.
9. Bagos P, Nikolopoulos G. A method for meta-analysis of case-control genetic association studies using logistic regression. Stat Appl Genet Mol Biol. 2007;6(1): 1-26.
10. Van Diemen CC, Postma DS, Vonk JM, etal. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med. 2005;172(3): 329-333.
11. Gosman MME, Boezen HM, van Diemen CC, etal. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax. 2007;62(3): 242-247.
12. Wang X, Li L, Xiao J, etal. Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population. BMC Med Genet. 2009;10(1): 132.
13. Sadeghnejad A, Ohar J, Zheng S, etal. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res. 2009;10(1): 21.
14. Pabst S, Touron CP, Gillissen A, etal. ADAM33 gene polymorphisms in chronic obstructive pulmonary disease. Eur J Med Res. 2009;14(Suppl 4): 182.
15. Ying-qiu Y, Ai-hua W. Association between ADAM33 gene polymorphism and chronic obstructive pulmonary disease. Chin J Nosocomiol. 2010;20(13): 1840-1843.
16. Xiao J, Han J, Wang X, etal. Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China. Mol Biol Rep. 2011;38(8): 4941-4945.
17. Chi X, Xiao W, Wang J, etal. Association between ADAM33 gene polymorphism and COPD. Shandong Med J. 2011;49: 002.
18. Zhou J-T, Sun Y-F. The relationship between ADAM33 S2 sit gene duration and disease course and age of the patients with COPD. Chin J of Clin Ration Drug Use. 2012;5(4B): 1-2.
19. Qin R-J, Wang H. Association between single nucleotide polymorphisms and haplotypes in ADAM33 gene and chronic obstructive pulmonary disease. Int J Respir. 2012;32(3): 182-187.
20. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003;22(1): 1-1.